May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Impact of Statin Use on New-Onset Uveitis
Author Affiliations & Notes
  • J. J. Yunker
    Retina Consultants of Alabama, Birmingham, Alabama
    Ophthalmology,
    University of Alabama at Birmingham, Birmingham, Alabama
  • G. McGwin, Jr.
    Department of Epidemiology, School of Public Health,
    University of Alabama at Birmingham, Birmingham, Alabama
  • R. W. Read
    Ophthalmology,
    University of Alabama at Birmingham, Birmingham, Alabama
  • Footnotes
    Commercial Relationships  J.J. Yunker, None; G. McGwin, None; R.W. Read, None.
  • Footnotes
    Support  Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4730. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. J. Yunker, G. McGwin, Jr., R. W. Read; Impact of Statin Use on New-Onset Uveitis. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4730. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effect of statin use on subsequent uveitis development.

Methods: : A case-control study was performed on patients from the Birmingham Veterans Affairs Medical Center (BVAMC) with a new diagnosis of uveitis occurring between 1997 and 2001, age-matched to non-uveitis controls. Patient data was reviewed for prior use of statin medications and selected systemic conditions. ICD-9 codes specific to uveitis were used to identify 92 incident cases of uveitis. These were matched 1:10 to control patients.Statistical analysis was performed to determine odds ratios for the incidence of uveitis between statin users and non-users, correlated with the duration of use of statin medications.

Results: : The use of statin medications was associated with a trend toward a 50% reduction in the risk of development of uveitis (OR 0.50, 95% CI 0.20-1.23). This association was present among both current (OR 0.46, 95% CI 0.15-1.46) and past (OR 0.54, 95% CI 0.18-1.67) statin users. Increasing duration of use was associated with greater reductions in risk, although not statistically significant.

Conclusions: : The use of statin medications was associated with a 50% reduced risk of uveitis. Future clinical studies may provide direct evidence of the effectiveness of statins in lowering the incidence and complications of uveitis.

Keywords: inflammation • autoimmune disease • clinical (human) or epidemiologic studies: prevalence/incidence 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×